Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Enzon Pharmaceuticals is slashing its workforce almost in half and cutting its operating costs to better align resources with its R&D activities. By June 2012, after the cuts go into effect, the New Jersey company will have 47 employees. Enzon uses customized PEGylation linker technology and mRNA-targeting agents to develop cancer therapeutics. Separately, Denmark’s NeuroSearch will reduce its workforce from almost 200 currently to about 50 a year from now. The firm is dropping most activities to focus on a Phase III study of its Huntington’s disease drug.
This article has been sent to the following recipient: